NO20006161L - Topisk tilförsel av oksazolidinoner for transdermal levering - Google Patents
Topisk tilförsel av oksazolidinoner for transdermal leveringInfo
- Publication number
- NO20006161L NO20006161L NO20006161A NO20006161A NO20006161L NO 20006161 L NO20006161 L NO 20006161L NO 20006161 A NO20006161 A NO 20006161A NO 20006161 A NO20006161 A NO 20006161A NO 20006161 L NO20006161 L NO 20006161L
- Authority
- NO
- Norway
- Prior art keywords
- topical administration
- oxazolidinones
- transdermal delivery
- infections
- bacteremia
- Prior art date
Links
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical class O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 title abstract 2
- 238000011200 topical administration Methods 0.000 title abstract 2
- 230000037317 transdermal delivery Effects 0.000 title 1
- 208000002874 Acne Vulgaris Diseases 0.000 abstract 1
- 208000031729 Bacteremia Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 208000005141 Otitis Diseases 0.000 abstract 1
- 206010062255 Soft tissue infection Diseases 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 206010000496 acne Diseases 0.000 abstract 1
- 208000019258 ear infection Diseases 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 206010040872 skin infection Diseases 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8828398P | 1998-06-05 | 1998-06-05 | |
| PCT/US1999/010463 WO1999062504A2 (en) | 1998-06-05 | 1999-05-26 | Topical administration of oxazolidinones for transdermal delivery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20006161L true NO20006161L (no) | 2000-12-04 |
| NO20006161D0 NO20006161D0 (no) | 2000-12-04 |
Family
ID=22210475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20006161A NO20006161D0 (no) | 1998-06-05 | 2000-12-04 | Topisk tilförsel av oksazolidinoner for transdermal levering |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US6613349B2 (pt) |
| EP (1) | EP1083900B1 (pt) |
| JP (1) | JP2002516852A (pt) |
| KR (1) | KR100626781B1 (pt) |
| CN (1) | CN1168447C (pt) |
| AT (1) | ATE220548T1 (pt) |
| AU (1) | AU749523B2 (pt) |
| BR (1) | BR9910318A (pt) |
| CA (1) | CA2327326A1 (pt) |
| CO (1) | CO5011042A1 (pt) |
| CZ (1) | CZ292420B6 (pt) |
| DE (1) | DE69902170T2 (pt) |
| DK (1) | DK1083900T3 (pt) |
| EA (1) | EA003699B1 (pt) |
| ES (1) | ES2179658T3 (pt) |
| HK (1) | HK1036593A1 (pt) |
| HU (1) | HU225234B1 (pt) |
| ID (1) | ID23775A (pt) |
| IL (1) | IL139843A0 (pt) |
| MY (1) | MY122454A (pt) |
| NO (1) | NO20006161D0 (pt) |
| NZ (1) | NZ508636A (pt) |
| PL (1) | PL193535B1 (pt) |
| PT (1) | PT1083900E (pt) |
| SK (1) | SK285352B6 (pt) |
| TR (1) | TR200003205T2 (pt) |
| TW (1) | TWI224000B (pt) |
| WO (1) | WO1999062504A2 (pt) |
| ZA (1) | ZA200005886B (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6562820B2 (en) | 2000-07-05 | 2003-05-13 | Pharmacia & Upjohn Company | Method for treatment and prevention of mastitis |
| WO2003030906A1 (en) * | 2001-10-11 | 2003-04-17 | Pharmacia & Upjohn Company | Treating infections by administration of oxazolidinones to the skin |
| BR0308806A (pt) * | 2002-03-29 | 2005-01-04 | Upjohn Co | Uso de oxazolidinonas para tratar infecções do tipo pé diabético |
| US20060222692A1 (en) * | 2005-03-31 | 2006-10-05 | Fairfield Clinical Trials Llc | Method and compositions for transdermal administration of antimicrobial medications |
| CN112409285A (zh) * | 2020-11-30 | 2021-02-26 | 山东金城昆仑药业有限公司 | 噁唑烷酮类化合物的晶型及其制备方法和应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3743727A (en) | 1970-11-16 | 1973-07-03 | Crown Zellerbach Corp | Enhancing tissue penetration of certain antimicrobial agents with dimethyl sulfoxide |
| US4507287A (en) | 1983-06-20 | 1985-03-26 | Dixon Glen J | Preparation and method for the treatment of acne |
| JP2558107B2 (ja) | 1986-12-18 | 1996-11-27 | 第一製薬株式会社 | 外用剤 |
| US4943435A (en) | 1987-10-05 | 1990-07-24 | Pharmetrix Corporation | Prolonged activity nicotine patch |
| US4960771A (en) | 1988-07-12 | 1990-10-02 | Rajadhyaksha Vithal J | Oxazolidinone penetration enhancing compounds |
| US5254577A (en) * | 1988-07-29 | 1993-10-19 | The Du Pont Merck Pharmaceutical Company | Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents |
| US5164510A (en) | 1988-09-15 | 1992-11-17 | The Upjohn Company | 5'Indolinyl-5β-amidomethyloxazolidin-2-ones |
| US5231188A (en) * | 1989-11-17 | 1993-07-27 | The Upjohn Company | Tricyclic [6.5.51]-fused oxazolidinone antibacterial agents |
| US5143928A (en) * | 1990-03-27 | 1992-09-01 | Warner-Lambert Company | 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents |
| AU667198B2 (en) | 1991-11-01 | 1996-03-14 | Pharmacia & Upjohn Company | Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents |
| TW203552B (en) * | 1992-02-18 | 1993-04-11 | J Baroody Lloyd | Compositions of clindamycin and benzoyl peroxide for acne treatment |
| US5457194A (en) * | 1993-03-17 | 1995-10-10 | Abbott Laboratories | Substituted aliphatic amine-containing macrocyclic immunomodulators |
| US5688792A (en) * | 1994-08-16 | 1997-11-18 | Pharmacia & Upjohn Company | Substituted oxazine and thiazine oxazolidinone antimicrobials |
| JP3698724B2 (ja) | 1993-11-22 | 2005-09-21 | ファルマシア・アンド・アップジョン・カンパニー | 置換−ヒドロキシアセチルピペラジンフェニルオキサゾリジノンのエステル |
| DE4425612A1 (de) | 1994-07-20 | 1996-04-04 | Bayer Ag | 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone |
| DE4425613A1 (de) | 1994-07-20 | 1996-01-25 | Bayer Ag | 5-gliedrige Heteroaryl-oxazolidinone |
| JP4102901B2 (ja) | 1994-09-14 | 2008-06-18 | スリーエム カンパニー | 経皮薬剤導入用マトリックス |
| US5604262A (en) * | 1995-03-22 | 1997-02-18 | Research Corporation Technologies, Inc. | Topical antimicrobial agents |
| ZA968661B (en) * | 1995-11-17 | 1998-04-14 | Upjohn Co | Oxazolidinone antibacterial agent with tricyclic substituents. |
| US5929086A (en) * | 1996-05-10 | 1999-07-27 | Pharmacia & Upjohn Company | Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases |
| NZ332719A (en) * | 1996-05-10 | 2000-01-28 | Upjohn Co | Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases |
| US6040306A (en) * | 1997-11-18 | 2000-03-21 | Pharmacia & Upjohn Company | Method of treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy |
| US6312715B1 (en) | 1998-05-01 | 2001-11-06 | 3M Innovative Properties Company | Adhesive microsphere drug delivery composition |
| US6174878B1 (en) * | 1999-08-31 | 2001-01-16 | Alcon Laboratories, Inc. | Topical use of kappa opioid agonists to treat otic pain |
-
1999
- 1999-05-18 MY MYPI99001940A patent/MY122454A/en unknown
- 1999-05-24 ID IDP990479D patent/ID23775A/id unknown
- 1999-05-26 WO PCT/US1999/010463 patent/WO1999062504A2/en active IP Right Grant
- 1999-05-26 EA EA200100010A patent/EA003699B1/ru not_active IP Right Cessation
- 1999-05-26 DE DE69902170T patent/DE69902170T2/de not_active Expired - Fee Related
- 1999-05-26 JP JP2000551760A patent/JP2002516852A/ja not_active Withdrawn
- 1999-05-26 PT PT99925598T patent/PT1083900E/pt unknown
- 1999-05-26 CA CA002327326A patent/CA2327326A1/en not_active Abandoned
- 1999-05-26 ES ES99925598T patent/ES2179658T3/es not_active Expired - Lifetime
- 1999-05-26 PL PL99345119A patent/PL193535B1/pl unknown
- 1999-05-26 KR KR1020007013712A patent/KR100626781B1/ko not_active IP Right Cessation
- 1999-05-26 DK DK99925598T patent/DK1083900T3/da active
- 1999-05-26 NZ NZ508636A patent/NZ508636A/en unknown
- 1999-05-26 US US09/320,428 patent/US6613349B2/en not_active Expired - Fee Related
- 1999-05-26 IL IL13984399A patent/IL139843A0/xx unknown
- 1999-05-26 SK SK1626-2000A patent/SK285352B6/sk unknown
- 1999-05-26 BR BR9910318-4A patent/BR9910318A/pt not_active Application Discontinuation
- 1999-05-26 AT AT99925598T patent/ATE220548T1/de not_active IP Right Cessation
- 1999-05-26 CZ CZ20004432A patent/CZ292420B6/cs not_active IP Right Cessation
- 1999-05-26 CN CNB998055093A patent/CN1168447C/zh not_active Expired - Fee Related
- 1999-05-26 EP EP99925598A patent/EP1083900B1/en not_active Expired - Lifetime
- 1999-05-26 HU HU0102191A patent/HU225234B1/hu not_active IP Right Cessation
- 1999-05-26 TR TR2000/03205T patent/TR200003205T2/xx unknown
- 1999-05-26 AU AU41848/99A patent/AU749523B2/en not_active Ceased
- 1999-05-28 TW TW088108864A patent/TWI224000B/zh not_active IP Right Cessation
- 1999-06-04 CO CO99035297A patent/CO5011042A1/es unknown
-
2000
- 2000-10-20 ZA ZA200005886A patent/ZA200005886B/en unknown
- 2000-12-04 NO NO20006161A patent/NO20006161D0/no not_active Application Discontinuation
-
2001
- 2001-10-29 HK HK01107513A patent/HK1036593A1/xx not_active IP Right Cessation
-
2003
- 2003-09-16 US US10/443,399 patent/US7892574B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Reyzelman et al. | Are antibiotics necessary in the treatment of locally infected ingrown toenails? | |
| KR910700048A (ko) | 오메프라졸의 항균제로서의 용도 | |
| US20110044917A1 (en) | Dental composition for treating peri-implantitis | |
| BR9510423A (pt) | Formulação lipossomal multilamelar de baixa rigidez processo de tratamento ou de profilaxia de uma infecção bacteriana em um animal e de uma variante mucoìde da mesma, uso da formulação lipossomal antibacteriana | |
| WO2005007072A3 (en) | Methods and pharmaceutical compositions for healing wounds | |
| DK1059934T3 (da) | Matrixproteinpræparater til sårheling | |
| AU3902299A (en) | Methods of treating microbial infection and therapeutic formulations therefor | |
| NO20006161L (no) | Topisk tilförsel av oksazolidinoner for transdermal levering | |
| Karlatti et al. | A comparative prospective study of preoperative antibiotic prophylaxis in the prevention of surgical site infections | |
| ATE245444T1 (de) | Pharmazeutische zusammensetzung, enthaltend peg- asparaginase, für die behandlung von hiv infektionen | |
| NO20044672L (no) | Parenteral, intravenos og oral administrering av oksazolidinoner for behandling av diabetiske fotinfeksjoner | |
| ES2160834T3 (es) | Derivado de fenil pirimidina opticamente activo como agente analgesico. | |
| ATE304886T1 (de) | Oxazolidinones zur behandlung von augeninfektionen | |
| UY26514A1 (es) | " composición para el tratamiento de tejidos danados". | |
| DE60030300D1 (de) | Topische behandlung zur vorbeugung von augeninfektionen | |
| BR0014751A (pt) | Composto, estereoisÈmero ou mistura de estereoisÈmeros, composição farmacêutica, método de tratamento de um paciente em necessidade de tratamento antimicrobiano, e, uso de um composto | |
| ECSP992967A (es) | Aplicación topica de oxazolidinonas para administracion transdermica | |
| Gustafson et al. | Effect of local application of trypsin on postextraction alveolar osteitis | |
| EP1053747A3 (de) | Mittel zur Behandlung lokaler parodontaler Infektionen | |
| SE9903499D0 (sv) | Antimicrobial agent for treatment and prophylaxis | |
| NO996117L (no) | Anordning for tilfoering av medikamenter samt behandling av virale og mikrobielle infeksjoner og taeringssyndrom | |
| NO20030483D0 (no) | Assosiasjoner av dalfopristin/quinupristin med cefpirom | |
| NO974941L (no) | Ny anvendelse av (S)-adenosyl-L-metionin(SAMe) | |
| UA33839A (uk) | Спосіб хірургічного лікування проникаючих поранень рогівки ока |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |